Jackeline Agorreta

Pamplona, NC, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

DSTYK inhibition increases the sensitivity of lung cancer cells to T cell-mediated cytotoxicity.

DSTYK inhibition increases the sensitivity of lung cancer cells to T cell-mediated cytotoxicity.

Journal: The Journal of experimental medicine

Published: April 26, 2022

Two cell line models to study multiorganic metastasis and immunotherapy in lung squamous cell carcinoma.

Two cell line models to study multiorganic metastasis and immunotherapy in lung squamous cell carcinoma.

Journal: Disease models & mechanisms

Published: May 27, 2021

SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation.

SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation.

Journal: Journal for immunotherapy of cancer

Published: January 12, 2021

PD-L1 expression correlates with tumor-infiltrating lymphocytes and better prognosis in patients with HPV-negative head and neck squamous cell carcinomas.

PD-L1 expression correlates with tumor-infiltrating lymphocytes and better prognosis in patients with HPV-negative head and neck squamous cell carcinomas.

Journal: Cancer immunology, immunotherapy : CII

Published: December 28, 2019

The SRC Inhibitor Dasatinib Induces Stem Cell-Like Properties in Head and Neck Cancer Cells that are Effectively Counteracted by the Mithralog EC-8042.

The SRC Inhibitor Dasatinib Induces Stem Cell-Like Properties in Head and Neck Cancer Cells that are Effectively Counteracted by the Mithralog EC-8042.

Journal: Journal of clinical medicine

Published: July 23, 2019

YES1 Drives Lung Cancer Growth and Progression and Predicts Sensitivity to Dasatinib.

YES1 Drives Lung Cancer Growth and Progression and Predicts Sensitivity to Dasatinib.

Journal: American journal of respiratory and critical care medicine

Published: June 06, 2019

Identification of mutations associated with acquired resistance to sunitinib in renal cell cancer.

Identification of mutations associated with acquired resistance to sunitinib in renal cell cancer.

Journal: International journal of cancer

Published: September 28, 2018

5 protein-based signature for resectable lung squamous cell carcinoma improves the prognostic performance of the TNM staging.

5 protein-based signature for resectable lung squamous cell carcinoma improves the prognostic performance of the TNM staging.

Journal: Thorax

Published: June 12, 2018

The oncogenic RNA-binding protein SRSF1 regulates LIG1 in non-small cell lung cancer.

The oncogenic RNA-binding protein SRSF1 regulates LIG1 in non-small cell lung cancer.

Journal: Laboratory investigation; a journal of technical methods and pathology

Published: May 14, 2018

A novel protein-based prognostic signature improves risk stratification to guide clinical management in early-stage lung adenocarcinoma patients.

A novel protein-based prognostic signature improves risk stratification to guide clinical management in early-stage lung adenocarcinoma patients.

Journal: The Journal of pathology

Published: February 21, 2018

Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16-mediated Effects.

Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16-mediated Effects.

Journal: American journal of respiratory and critical care medicine

Published: January 13, 2018

Complement C4d-specific antibodies for the diagnosis of lung cancer.

Complement C4d-specific antibodies for the diagnosis of lung cancer.

Journal: Oncotarget

Published: November 10, 2017

Showing 1-12 of 32

Last Updated: 09/26/2026